“The most effective way to move from target identification to the clinic is to identify already approved drugs with the potential for activating or inhibiting unintended targets.” (S Dakshanamurthy et al, J Med Chem, 2012, 55(15), pp6832–6848.)
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact customerservices@lexology.com
RegisterPatent protection for new uses of known drugs
To view this article you need a PDF viewer such as Adobe Reader.
Global
December 17 2012
If you would like to learn how Lexology can drive your content marketing strategy forward, please email enquiries@lexology.com.
Featured Video
Related topic hubs
Onno Rijsdijk
Director, Legal
CAE Aviation
What our clients say
"I am a frequent reader of Lexology as it is an efficient and concise service. It is very relevant as a large part of these communications come from law firms, who have a clear interest in marketing their organizations expertise in key areas of business law"
